145 related articles for article (PubMed ID: 37020834)
1. Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study.
Gharib AR; Jensen PN; Psaty BM; Hoofnagle AN; Siscovick D; Gharib SA; Sitlani CM; Sotoodehnia N; Lemaitre RN
ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37020834
[TBL] [Abstract][Full Text] [Related]
2. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
Bockus LB; Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
JAMA Netw Open; 2023 Nov; 6(11):e2343854. PubMed ID: 37976059
[TBL] [Abstract][Full Text] [Related]
3. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
[TBL] [Abstract][Full Text] [Related]
4. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
5. Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study.
Fretts AM; Jensen PN; Hoofnagle A; McKnight B; Howard BV; Umans J; Yu C; Sitlani C; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
J Nutr; 2020 May; 150(5):1214-1222. PubMed ID: 31665380
[TBL] [Abstract][Full Text] [Related]
6. Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
Clin Chem; 2021 Nov; 67(12):1650-1659. PubMed ID: 34580702
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipids and physical function in the Atherosclerosis Risk in Communities (ARIC) study.
Li D; Alam AB; Yu F; Kucharska-Newton A; Windham BG; Alonso A
Sci Rep; 2021 Jan; 11(1):1169. PubMed ID: 33441925
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics Reveals Dysregulated Sphingolipid and Amino Acid Metabolism Associated with Chronic Obstructive Pulmonary Disease.
Kim J; Suresh B; Lim MN; Hong SH; Kim KS; Song HE; Lee HY; Yoo HJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2022; 17():2343-2353. PubMed ID: 36172036
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
10. Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.
Lemaitre RN; Jensen PN; Hoofnagle A; McKnight B; Fretts AM; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N
Circ Heart Fail; 2019 Jul; 12(7):e005708. PubMed ID: 31296099
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelins and ceramides: possible biomarkers for dementia?
Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
[TBL] [Abstract][Full Text] [Related]
12. Exploring polar headgroup interactions between sphingomyelin and ceramide with infrared spectroscopy.
de la Arada I; González-Ramírez EJ; Alonso A; Goñi FM; Arrondo JR
Sci Rep; 2020 Oct; 10(1):17606. PubMed ID: 33077787
[TBL] [Abstract][Full Text] [Related]
13. Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Howard BV; Umans J; Sitlani CM; Siscovick DS; King IB; Djousse L; Sotoodehnia N; Lemaitre RN
J Lipid Res; 2021; 62():100119. PubMed ID: 34555371
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells.
Momchilova A; Pankov R; Staneva G; Pankov S; Krastev P; Vassileva E; Hazarosova R; Krastev N; Robev B; Nikolova B; Pinkas A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142801
[TBL] [Abstract][Full Text] [Related]
15. Meibum sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids.
Galor A; Sanchez V; Jensen A; Burton M; Maus K; Stephenson D; Chalfant C; Mandal N
Ocul Surf; 2022 Jan; 23():87-95. PubMed ID: 34861426
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease.
You Q; Peng Q; Yu Z; Jin H; Zhang J; Sun W; Huang Y
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830858
[TBL] [Abstract][Full Text] [Related]
17. Homogeneous and Heterogeneous Bilayers of Ternary Lipid Compositions Containing Equimolar Ceramide and Cholesterol.
González-Ramírez EJ; Artetxe I; García-Arribas AB; Goñi FM; Alonso A
Langmuir; 2019 Apr; 35(15):5305-5315. PubMed ID: 30924341
[TBL] [Abstract][Full Text] [Related]
18. The equilibria of sphingolipid-cholesterol and sphingolipid-sphingolipid in monolayers at the air-water interface.
Petelska AD; Figaszewski ZA
J Membr Biol; 2013 Jan; 246(1):13-9. PubMed ID: 22899351
[TBL] [Abstract][Full Text] [Related]
19. Limonoid compounds inhibit sphingomyelin biosynthesis by preventing CERT protein-dependent extraction of ceramides from the endoplasmic reticulum.
Hullin-Matsuda F; Tomishige N; Sakai S; Ishitsuka R; Ishii K; Makino A; Greimel P; Abe M; Laviad EL; Lagarde M; Vidal H; Saito T; Osada H; Hanada K; Futerman AH; Kobayashi T
J Biol Chem; 2012 Jul; 287(29):24397-411. PubMed ID: 22605339
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Plasma and Milk Sphingolipids in Dairy Cows Fed High-Starch Diets.
Rico JE; Sandri EC; Sarmiento AC; Lévesque J; Kenéz Á; Rico DE
Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
